AMZN
Amazon.com, Inc.
AMZN has the edge over COLM overall, supported by stronger modeled upside and stronger valuation.
COLM
Columbia Sportswear Company
COLM offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
COLM Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Strong |
COLM's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN has the edge over COLM in the historical PE scenario, which offers more potential upside but is not a forecast.
COLM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $69.30 | -3.3% |
| Current | 16x | $71.64 | — |
| Forward | 17x | $71.64 | — |
| Fair | 18x | $83.30 | +16% |
| Expensive | 26x | $117 | +63% |
Historical ranges are pointers, not guarantees.
COLM's PE is in its cheap range at 16x. On analysts' estimates for next year's earnings, today's price would be 17x.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
COLM Forward outlook
| Metric | Outlook |
|---|---|
| Deteriorating | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for COLM, with profitability improving.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over COLM on earnings, with more consistent year-over-year improvement.
COLM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.34 | -4.8% |
| Q3 2026 | $4.56 | +40% |
| Q2 2026 | $3.85 | -0.5% |
| Q1 2026 | $3.14 | -19% |
| Q4 2025 | $3.24 | -15% |
| Q3 2025 | $3.26 | -8.9% |
| Q2 2025 | $3.87 | +4% |
| Q1 2025 | $3.86 | -4.9% |
| Q4 2024 | $3.82 | -6.6% |
COLM earned $4.56 per share over the past year, up 40% from the year before.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over COLM on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over COLM on profitability, with a higher operating margin.
COLM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $962.6M | +2% |
| Q2 2026 | $614.4M | +1.5% |
| Q1 2026 | $779M | +0.1% |
| Q4 2025 | $1.1B | -2.4% |
| Q3 2025 | $943.4M | +1.3% |
| Q2 2025 | $605.2M | +6.1% |
| Q1 2025 | $778.5M | +1.1% |
| Q4 2024 | $1.1B | +3.5% |
COLM's revenue fell from its 2022 peak and has held roughly level since: $963M last quarter, up 2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 11% | +4.3 points |
| Q2 2026 | 5% | +8.9 points |
| Q1 2026 | 5.4% | -0.6 points |
| Q4 2025 | 11% | -1.6 points |
| Q3 2025 | 7.1% | -4.9 points |
| Q2 2025 | -3.9% | +0.3 points |
| Q1 2025 | 6% | +0.2 points |
| Q4 2024 | 13% | +1.8 points |
COLM's operating margin was 11% last quarter, up 4.3 points from the same quarter a year ago.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
COLM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$333M | -$45.8M |
| Q2 2026 | $101.6M | +$147M |
| Q1 2026 | -$90M | -$42.4M |
| Q4 2025 | $596.8M | +8.6% |
| Q3 2025 | -$287.2M | -$87.7M |
| Q2 2025 | -$45.3M | -$34.4M |
| Q1 2025 | -$47.6M | -152% |
| Q4 2024 | $549.6M | -8.5% |
COLM has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has 10.9B diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
COLM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.6% | -318K shares |
| 1 year | -6.6% | -3.6M shares |
| 3 years | -16% | -10M shares |
| 5 years | -23% | -15.3M shares |
| Available history | -26% | -17.5M shares |
COLM has the edge over AMZN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $50M |
| Q2 2026 | — |
| Q1 2026 | $150M |
| Q4 2025 | $29.4M |
| Q3 2025 | $40M |
| Q2 2025 | $30.3M |
| Q1 2025 | $101.4M |
| Q4 2024 | $86.9M |
COLM spent $229M buying back its own shares over the past year, down 11% from the year before.
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
COLM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.6x | Net Cash |
| Q2 2026 | -1.7x | Net Cash |
| Q1 2026 | -1.2x | Net Cash |
| Q4 2025 | -1.7x | Net Cash |
| Q3 2025 | -0.8x | Net Cash |
| Q2 2025 | -1.3x | Net Cash |
| Q1 2025 | -1.0x | Net Cash |
| Q4 2024 | -1.6x | Net Cash |
COLM has the edge over AMZN on leverage, with a lower net debt burden relative to earnings.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
COLM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 71.0 | Overbought |
| Stochastic | 92.5 | Overbought |
COLM's weekly RSI is 71 (overbought) and its Stochastic is 93 (overbought).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
COLM PE vs Consumer Cyclical Sector
| Metric | COLM | Sector median | Relative |
|---|---|---|---|
| PE | 16x | 18x | 13% below |
| PE % | 21 | 47 | 26 pts below |
COLM has the edge over AMZN on valuation relative to its sector.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN is in an uptrend: it's above all five of its weekly moving averages, and 40% above its 200-week average.
COLM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $62.9 | 14% above |
| 20 week MA | $61.0 | 18% above |
| 50 week MA | $60.0 | 19% above |
| 100 week MA | $62.8 | 14% above |
| 200 week MA | $71.6 | 0.1% above |
COLM has climbed back above all five of its weekly moving averages, and it's now 0.1% above its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has finished higher in five of the last six years, two of them by more than 50%. It's up 15% so far in 2026.
COLM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $99.7 | $90.2 | -9.5% |
| 2021 | $90.2 | $93.8 | +4% |
| 2022 | $93.8 | $85.9 | -8.4% |
| 2023 | $85.9 | $79.5 | -7.4% |
| 2024 | $79.5 | $85.8 | +7.8% |
| 2025 | $85.8 | $55.6 | -35% |
| 2026 YTD | $55.6 | $71.6 | +29% |
COLM has the edge over AMZN on returns for 2026, with the stronger performance.